Opioid-Induced Constipation Market Trends, Epidemiology, and Unmet Needs to 2034: 7MM Projected to Reach $1.16 Billion Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Opioid-Induced Constipation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...

Constipation Treatment Market Projected to Reach $27.5 Billion by 2030, as Laxatives Segment Accelerates Globally Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Constipation Treatment: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Emerging Trends and High Growth...

Constipation Treatment Global Market Report 2023: Growth Trajectories, Product Innovations, and Strategic Acquisitions to 2033 Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Constipation Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The constipation treatment sector is...

Rapid Approval of Pipeline Drugs to Augment Opioid Induced Constipation Treatment Market – TMR Albany, New York, June 14, 2019 (GLOBE NEWSWIRE) -- Opioids are drugs, which when used in a certain proportion, work as pain killers and medicines for medical ailments, such as diarrhea and...

Sucampo Announces Presentation of Results on AMITIZA(R) (lubiprostone) in Opioid-Induced Constipation at Two Upcoming Scientific Conferences BETHESDA, Md., Oct. 11, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo") today announced the presentation of three posters evaluating AMITIZA® (lubiprostone) in...